Venkata Deepthi Vemuri, Rekharani Kushwaha, Gollu Gowri, Nalini Mathala, Swathi Nalla, Sasikala Allam & Gurijala Lekhya. (2023) An Overview on Macrophage Targeting: A Promising Approach. Critical Reviews™ in Therapeutic Drug Carrier Systems 40:5, pages 47-92.
Crossref
Sooyoung Shin, Soonbum Kwon & Yoon Yeo. (2022) Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections. Pharmaceutical Research 39:6, pages 1085-1114.
Crossref
Merve Karpuz & Mine Silindir‐Gunay. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials
469
503
.
Jing Huang, Jiquan Guo, Xiaoling Zou, Jiaxin Zhu, Shaozhu Wu & Tiantuo Zhang. (2021)
Bioinspired Heteromultivalent Chitosan-
α
-Fe
2
O
3
/Gadofullerene Hybrid Composite for Enhanced Antibiotic-Resistant Bacterial Pneumonia
. Journal of Biomedical Nanotechnology 17:6, pages 1217-1228.
Crossref
V.N. Azger Dustachkeer, Christy Rosaline Nirmal, Sam Ebenezer Rajadas, Shainaba A. Saadhali, Silambuchelvi Kannayan & Vishnu Priya Padmanaban. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy
149
173
.
Chad W. Stratilo, Scott Jager, Melissa Crichton & James D. Blanchard. (2020) Evaluation of liposomal ciprofloxacin formulations in a murine model of anthrax. PLOS ONE 15:1, pages e0228162.
Crossref
Danielle S.W. Benoit, Clyde T. Overby, Kenneth R. Sims Jr.Marian A. Ackun-Farmmer. 2020. Biomaterials Science. Biomaterials Science
1237
1266
.
Sergey Zaichik, Christian Steinbring, Claudia Menzel, Ludwig Knabl, Dorothea Orth-Höller, Helmut Ellemunter, Katharina Niedermayr & Andreas Bernkop-Schnürch. (2018) Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin with improved mucus permeating properties. International Journal of Pharmaceutics 547:1-2, pages 282-290.
Crossref
Ruba S. Darweesh & Masahiro Sakagami. (2018) In vitro lung epithelial cell transport and anti-interleukin-8 releasing activity of liposomal ciprofloxacin. European Journal of Pharmaceutical Sciences 115, pages 68-76.
Crossref
Diego Maselli, Holly Keyt & Marcos Restrepo. (2017) Inhaled Antibiotic Therapy in Chronic Respiratory Diseases. International Journal of Molecular Sciences 18:5, pages 1062.
Crossref
Karleigh A. Hamblin, Stuart J. Armstrong, Kay B. Barnes, Carwyn Davies, Thomas Laws, James D. Blanchard, Sarah V. Harding & Helen S. Atkins. (2017) Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague. Frontiers in Microbiology 8.
Crossref
Shuyu Xie, Fei Yang, Yanfei Tao, Dongmei Chen, Wei Qu, Lingli Huang, Zhenli Liu, Yuanhu Pan & Zonghui Yuan. (2017) Enhanced intracellular delivery and antibacterial efficacy of enrofloxacin-loaded docosanoic acid solid lipid nanoparticles against intracellular Salmonella. Scientific Reports 7:1.
Crossref
Abel M. Maharramov, Mahammadali A. Ramazanov & Ulviyya A. Hasanova. 2017. Antimicrobial Nanoarchitectonics. Antimicrobial Nanoarchitectonics
445
473
.
Adriano Brandelli, Cristian Mauricio Barreto Pinilla & Nathalie Almeida Lopes. 2017. Nanotechnology Applied To Pharmaceutical Technology. Nanotechnology Applied To Pharmaceutical Technology
55
90
.
Yihua Pei & Yoon Yeo. (2016) Drug delivery to macrophages: Challenges and opportunities. Journal of Controlled Release 240, pages 202-211.
Crossref
Yukimune Kanehira, Kohei Togami, Hitoshi Tada & Sumio Chono. (2016) Tumor distribution and anti-tumor effect of doxorubicin following intrapulmonary administration to mice with metastatic lung tumor. Journal of Drug Delivery Science and Technology 33, pages 143-148.
Crossref
Catherine Ladavière & Ruxandra Gref. (2015) Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems. Nanomedicine 10:19, pages 3033-3055.
Crossref
Athanasios Chatzimoschou, Maria Simitsopoulou, Charalampos Antachopoulos, Thomas J. Walsh & Emmanuel Roilides. (2015) Antipseudomonal Agents Exhibit Differential Pharmacodynamic Interactions with Human Polymorphonuclear Leukocytes against Established Biofilms of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 59:4, pages 2198-2205.
Crossref
Padma V. Devarajan, Shilpa M. Dawre & Rinku Dutta. 2015. Targeted Drug Delivery : Concepts and Design. Targeted Drug Delivery : Concepts and Design
113
148
.
Shuyu Xie, Yanfei Tao, Yuanhu Pan, Wei Qu, Guyue Cheng, Lingli Huang, Dongmei Chen, Xu Wang, Zhenli Liu & Zonghui Yuan. (2014) Biodegradable nanoparticles for intracellular delivery of antimicrobial agents. Journal of Controlled Release 187, pages 101-117.
Crossref
David Cipolla, Boris Shekunov, Jim Blanchard & Anthony Hickey. (2014) Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans. Advanced Drug Delivery Reviews 75, pages 53-80.
Crossref
Misagh Alipour & Zacharias E Suntres. (2014)
Liposomal antibiotic formulations for targeting the lungs in the treatment of
Pseudomonas aeruginosa
. Therapeutic Delivery 5:4, pages 409-427.
Crossref
Frank BoehmMisagh Alipour, Abdelwahab Omri & Zacharias Suntres. 2013. Nanomedical Device and Systems Design. Nanomedical Device and Systems Design
455
490
.
Julie Ann Justo, Larry H. Danziger & Mark H. Gotfried. (2013) Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis. Therapeutic Advances in Respiratory Disease 7:5, pages 272-287.
Crossref
Hui Xin Ong, Daniela Traini, Mary Bebawy & Paul M. Young. (2013) Ciprofloxacin Is Actively Transported across Bronchial Lung Epithelial Cells Using a Calu-3 Air Interface Cell Model. Antimicrobial Agents and Chemotherapy 57:6, pages 2535-2540.
Crossref
Pritam Sahota, James Popp, Jerry Hardisty & Chirukandath GopinathDavid Lewis & Tom McKevitt. 2013. Toxicologic Pathology. Toxicologic Pathology
367
420
.
Susana Andrea Breda, Maria Laura Guzmán, Alejandra Confalonieri, Claudia González, Monica Sparo, Ruben Hilario Manzo, Sergio Sánchez Bruni & Maria Eugenia Olivera. (2013)
Systemic Exposure, Tissue Distribution, and Disease Evolution of a High Solubility Ciprofloxacin–Aluminum Complex in a Murine Model of Septicemia Induced by
Salmonella enterica
Serotype Enteritidis
. Molecular Pharmaceutics 10:2, pages 598-605.
Crossref
Kazuhiro Morimoto. (2013) Designs of Optimized Microbial Therapy Systems of Respiratory Infections呼吸器感染症の抗菌薬を用いた最適治療法の構築. YAKUGAKU ZASSHI 133:1, pages 81-92.
Crossref
Tiago dos Santos, Juan Varela, Iseult Lynch, Anna Salvati & Kenneth A. Dawson. (2011) Quantitative Assessment of the Comparative Nanoparticle-Uptake Efficiency of a Range of Cell Lines. Small 7:23, pages 3341-3349.
Crossref
Keith A. Rodvold, Jomy M. George & Liz Yoo. (2011) Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid. Clinical Pharmacokinetics 50:10, pages 637-664.
Crossref
Ben Forbes, Bahman Asgharian, Lea Ann Dailey, Douglas Ferguson, Per Gerde, Mark Gumbleton, Lena Gustavsson, Colin Hardy, David Hassall, Rhys Jones, Ruth Lock, Janet Maas, Tim McGovern, Gary R. Pitcairn, Graham Somers & Ron K. Wolff. (2011) Challenges in inhaled product development and opportunities for open innovation. Advanced Drug Delivery Reviews 63:1-2, pages 69-87.
Crossref
K.D. Bruce, G.B. Rogers & N. Patel. (2011) Microbiological insights into respiratory infections and the opportunities for inhaled therapy. Journal of Drug Delivery Science and Technology 21:4, pages 301-309.
Crossref
Janani Swaminathan & Carsten Ehrhardt. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
313
334
.